News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
307 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17994)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (249)
2 (227)
3 (175)
4 (72)
5 (2)
6 (9)
7 (175)
8 (219)
9 (161)
10 (259)
11 (113)
12 (7)
13 (2)
14 (172)
15 (304)
16 (260)
17 (238)
18 (120)
19 (1)
20 (3)
21 (214)
22 (269)
23 (243)
24 (278)
25 (118)
26 (3)
27 (18)
28 (238)
29 (307)
30 (277)
31 (323)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Y-mAbs Announces Proposed Public Offering of Common Stock
Y-mAbs Therapeutics, Inc. announced the commencement of a registered underwritten public offering of up to $125 million in shares of its common stock.
October 29, 2019
·
5 min read
Policy
Digital submission of adverse event reports for investigational new drug applications reflects FDA’s ongoing modernization efforts
The U.S. Food and Drug Administration is taking steps towards requiring electronic submission of certain safety reports for products being evaluated by the FDA under an investigational new drug application into the FDA’s Adverse Event Reporting System The planned process for submissions is outlined in a new draft guidance, and the FDA is also making available supporting technical specification documents.
October 29, 2019
·
5 min read
BioCapital
QIAGEN’s QuantiFERON®-TB Gold Plus Test Added to the Global Drug Facility Catalog for Public Health Efforts
QIAGEN expands market for gold standard latent TB test to help developing countries fight TB
October 29, 2019
·
1 min read
BioMidwest
Hillrom to Present at the Stifel 2019 Healthcare Conference
Hillrom announced that it will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019, in New York.
October 29, 2019
·
1 min read
BioForest
OHSU, OCHIN awarded $7.2 million NIH grant to implement cancer prevention strategies
New center of excellence aims to improve rates of cervical cancer screening, tobacco cessation
October 29, 2019
·
4 min read
Genetown
AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection)Company to Comment During Third Quarter Financial Results Conference Call on Friday, November 1, 2019, at 8:00 a.m. ET
The advisory committee’s recommendation, while not binding, will be considered by the FDA in making its decision.
October 29, 2019
·
7 min read
Business
CORRECTING and REPLACING Cook Medical and Quanta System Announce Distribution Agreement for Laser Systems
Cook Medical and Quanta System have entered into an agreement in which Cook will distribute in some territories a comprehensive offering of Quanta’s holmium and thulium laser systems, laser fibers and accessories.
October 29, 2019
·
3 min read
BioCapital
Statement from Acting FDA Commissioner Ned Sharpless, M.D., and Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research, on FDA’s new report regarding root causes and potential solutions to drug shortages
One of the U.S. Food and Drug Administration’s top priorities is to ensure that Americans have access to safe and effective medicines
October 29, 2019
·
8 min read
Leveraging Patient Journey Mapping to Uncover New Insights & Explore Future Growth Opportunities Within the Cardiovascular Drugs Segment | A Case Study by Quantzig
Quantzig, a global data analytics and advisory firm that delivers actionable analytics solutions to resolve complex business problems, has announced the completion of its latest success story that highlights how ‘Patient Journey Mapping Helped a Pharma Company to Uncover New Insights and Explore Future Growth Opportunities Within the Cardiovascular Drugs Segment.’
October 29, 2019
·
2 min read
Business
ARS Treatment Centers Announces Opening of New Opioid Addiction Treatment Clinic in Paterson, NJ
ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Paterson, New Jersey.
October 29, 2019
·
2 min read
Previous
20 of 31
Next